Respirogen™ Micro-Oxygen (RMO) technology provides systemic oxygen delivery to the body without using the lungs, treating systemic hypoxia in lung injury COVID and ARDS patients by creating novel breakthrough therapy.
Industry: Therapeutics
Funding Stage: Seed Round